| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K52037352 |
| PharmacoGx | BRD-K52037352 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRKCDBP | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | BCL2L13 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | FAXC | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | RFESD | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | GTDC1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | EPC2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | L3HYPDH | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | PPP1R32 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | GABRG1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | AC073610.5 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
